High materiality8/10
Wolfe Research Reiterates Outperform Rating on AnaptysBio (ANAB)
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wolfe Research reiterates Outperform on ANAB; target $78; current price $56.28.
- Outperform rating reiterated; target $78; current price $56.28.
Key facts
- 01
Target: $78
- 02
Posted price: $56.28
- 03
Analyst firm: Wolfe Research
- 04
Analyst: Andy Chen
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.